| scholarly article | Q13442814 |
| P2093 | author name string | Richard Shumway | |
| Emily J Anstadt | |||
| David Grew | |||
| Joseph Colasanto | |||
| P2860 | cites work | Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases | Q83412928 |
| Central liver toxicity after SBRT: An expanded analysis and predictive nomogram | Q88801639 | ||
| Stereotactic body radiation therapy for liver metastases | Q27008308 | ||
| Phase I study of individualized stereotactic body radiotherapy of liver metastases. | Q33383521 | ||
| Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases | Q33874670 | ||
| Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. | Q33928286 | ||
| Impact of hospital volume on operative mortality for major cancer surgery | Q34482407 | ||
| A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions | Q34723820 | ||
| Institutional clinical trial accrual volume and survival of patients with head and neck cancer | Q34786079 | ||
| Stereotactic body radiation therapy for liver metastases from colorectal cancer: analysis of safety, feasibility, and early outcomes | Q35971469 | ||
| A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases | Q36415438 | ||
| Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience | Q37601179 | ||
| Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base | Q38620191 | ||
| Stereotactic body radiation therapy for primary and metastatic liver tumors: From technological evolution to improved patient care | Q38819733 | ||
| Should operations be regionalized? The empirical relation between surgical volume and mortality | Q42595587 | ||
| Impact of facility volume on therapy and survival for locally advanced cervical cancer | Q43425343 | ||
| Hospital volume and surgical mortality in the United States. | Q44464097 | ||
| Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer | Q44779587 | ||
| Facility Volume and Survival in Nasopharyngeal Carcinoma | Q46231475 | ||
| Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. | Q50639034 | ||
| Relationship between hospital volume and late survival after pancreaticoduodenectomy. | Q50651012 | ||
| Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship? | Q50686259 | ||
| Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. | Q52142739 | ||
| Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases. | Q53226155 | ||
| High Procedure Volume Is Strongly Associated With Improved Survival After Lung Cancer Surgery | Q59825838 | ||
| Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer | Q61054503 | ||
| Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy in Patients With Hepatic Metastases | Q82288170 | ||
| Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases | Q83412925 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gastroenterology | Q120569 |
| Community hospitals | Q36920699 | ||
| P304 | page(s) | 330-338 | |
| P577 | publication date | 2019-04-01 | |
| P1433 | published in | Journal of gastrointestinal oncology | Q26842467 |
| P1476 | title | Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases | |
| P478 | volume | 10 |
Search more.